Sign in
KRRO Stock Price, Chart, Stats & News
Korro Bio, Inc.
Save
Korro Bio, Inc. (KRRO) does not currently pay a dividend.
129.69M
Market cap
–
Current P/E
–
Forward P/E
KRRO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 89.85% |
Operating margin | -1366.43% |
Pretax margin | -1824.52% |
Net margin | -1834.48% |
Effective tax rate | -0.55% |
ROA | -103.31% |
ROE | -115.95% |
D/E | 0.85x |
Interest coverage ratio | – |
KRRO valuation
P/E | – |
P/S | 15.29x |
P/B | 1.90x |
P/CF | -1.24x |
P/FCF | -1.24x |
P/OCF | -1.24x |
PEG | 0.03x |
EV multiple | -0.93x |
About
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics.
Similar securities
Based on sector and market capitalization
Report issue